San Antonio-based nonprofit BioBridge Global has added orthopedic surgeon Michael J. Yaszemski, MD, PhD, to its regenerative medicine advisory board.
Biologics
New York-based medical device manufacturer Misonix agreed to acquire privately held wound-healing company Solys Medical of Newport News, Va., in an all-stock transaction valued at $97 million.
Biomedical engineers and researchers from North Carolina State University, N.C., have partnered with University of North Carolina, N.C., scientists to create new body tissues using a patient's own cells, which may help more patients avoid knee replacement surgery, reports WRAL,…
A Montana therapeutic drug developer and California biotech company have agreed to collaborate on novel approaches for treating disorders of the central nervous system.
Stem cell treatments are experimental in orthopedics, but their use is promising, according to Jeffrey Carroll, MD.
A new study published in Spine examines hospital resource utilization for spine surgery patients who need treatment for Staphylococcus aureus infection with 180 days of surgery.
A new study from Market Research Gazette examines the spinal fusion market.
Altrua HealthShare and Regenexx partnered to offer Altrua members access to Regenexx's regenerative medicine treatments.
UC San Francisco department of orthopedic surgery researcher Annarita Scaramozza, PhD, has made a discovery that could boost recovery from radiation therapy for cancer treatment with 'super hero' stem cells.
A new study published in Spine compares open and Wiltse minimally invasive transforaminal lumbar interbody fusion outcomes.
